EDAR Antikörper
-
- Target Alle EDAR Antikörper anzeigen
- EDAR (Ectodysplasin A Receptor (EDAR))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EDAR Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human EDAR
- Isotyp
- IgG
- Top Product
- Discover our top product EDAR Primärantikörper
-
-
- Applikationshinweise
- IHC 1:35-1:150
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.3 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- EDAR (Ectodysplasin A Receptor (EDAR))
- Andere Bezeichnung
- EDAR (EDAR Produkte)
- Hintergrund
- This gene encodes a member of the tumor necrosis factor receptor family. The encoded transmembrane protein is a receptor for the soluble ligand ectodysplasin A, and can activate the nuclear factor-kappaB, JNK, and caspase-independent cell death pathways. It is required for the development of hair, teeth, and other ectodermal derivatives. Mutations in this gene result in autosomal dominant and recessive forms of hypohidrotic ectodermal dysplasia.
- NCBI Accession
- NP_071731
- UniProt
- Q9UNE0
- Pathways
- Tube Formation, Ubiquitin Proteasome Pathway
-